SCHEMBL7912433

SCHEMBL7912433

O=C(c1ccc(-c2ccc(F)cc2)cc1)N1CCC(c2ccccc2)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.78
RAB9A P51151 1/20 0.78
ATM Q13315 1/20 0.78
HSD11B1 P28845 4/20 0.70
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
KDM4E B2RXH2 2/20 0.67
ALDH1A1 P00352 2/20 0.67
CA12 O43570 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
CA7 P43166 1/20 0.62
CA9 Q16790 1/20 0.62
CA14 Q9ULX7 1/20 0.62
SLC6A7 Q99884 1/20 0.61
PARP10 Q53GL7 1/20 0.60
HTR2B P41595 2/20 0.59
NAMPT P43490 1/20 0.58
PTPN1 P18031 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786718 0.96 NPC1 (0.84) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL27629062 0.90 NPC1 (0.74) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL10720211 0.88 CA12 (0.76) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL4206605 0.85 CA12 (0.71) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL13212972 0.81 CA12 (0.71) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL95659 0.81 CA12 (0.67) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL8160698 0.81 HSD11B1 (0.66) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL3455533 0.81 RAB9A (0.87) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL1299004 0.80 HTR2B (0.62) NPC1RAB9AATMHSD11B1MEN1
SCHEMBL13952062 0.80 HSD11B1 (0.61) NPC1RAB9AATMHSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010106081-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-23 WO disclosed